{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25555059", "DateCompleted": {"Year": "2016", "Month": "02", "Day": "29"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "01", "Day": "29"}], "ELocationID": ["10.1021/ci500405g"], "Language": ["eng"], "Journal": {"ISSN": "1549-960X", "JournalIssue": {"Volume": "55", "Issue": "2", "PubDate": {"Year": "2015", "Month": "Feb", "Day": "23"}}, "Title": "Journal of chemical information and modeling", "ISOAbbreviation": "J Chem Inf Model"}, "ArticleTitle": "A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity.", "Pagination": {"StartPage": "308", "EndPage": "316", "MedlinePgn": "308-16"}, "Abstract": {"AbstractText": ["Recent outbreaks of highly pathogenic and occasional drug-resistant influenza strains have highlighted the need to develop novel anti-influenza therapeutics. Here, we report computational and experimental efforts to identify influenza neuraminidase inhibitors from among the 3000 natural compounds in the Malaysian-Plants Natural-Product (NADI) database. These 3000 compounds were first docked into the neuraminidase active site. The five plants with the largest number of top predicted ligands were selected for experimental evaluation. Twelve specific compounds isolated from these five plants were shown to inhibit neuraminidase, including two compounds with IC50 values less than 92 \u03bcM. Furthermore, four of the 12 isolated compounds had also been identified in the top 100 compounds from the virtual screen. Together, these results suggest an effective new approach for identifying bioactive plant species that will further the identification of new pharmacologically active compounds from diverse natural-product resources."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Malaysian Institute of Pharmaceuticals and Nutraceuticals, Ministry of Science, Technology and Innovation , Jalan Bukit Gambir, 11800, Penang, Malaysia."}], "LastName": "Ikram", "ForeName": "Nur Kusaira Khairul", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Durrant", "ForeName": "Jacob D", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Muchtaridi", "ForeName": "Muchtaridi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zalaludin", "ForeName": "Ayunni Salihah", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Purwitasari", "ForeName": "Neny", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mohamed", "ForeName": "Nornisah", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Rahim", "ForeName": "Aisyah Saad Abdul", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lam", "ForeName": "Chan Kit", "Initials": "CK"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Normi", "ForeName": "Yahaya M", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Rahman", "ForeName": "Noorsaadah Abd", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Amaro", "ForeName": "Rommie E", "Initials": "RE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wahab", "ForeName": "Habibah A", "Initials": "HA"}], "GrantList": [{"GrantID": "DP2 OD007237", "Acronym": "OD", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Chem Inf Model", "NlmUniqueID": "101230060", "ISSNLinking": "1549-9596"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthones"}, {"RegistryNumber": "0", "NameOfSubstance": "garcinone C"}, {"RegistryNumber": "EC 3.2.1.18", "NameOfSubstance": "Neuraminidase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Databases, Chemical"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "False Positive Reactions"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": ["methods"], "DescriptorName": "High-Throughput Screening Assays"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["enzymology"], "DescriptorName": "Influenza A Virus, H5N1 Subtype"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Influenza, Human"}, {"QualifierName": [], "DescriptorName": "Malaysia"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Neuraminidase"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Xanthones"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Webster R. G.; Peiris M.; Chen H. L.; Guan Y. H5N1 Outbreaks and Enzootic Influenza. Emerging Infect. Dis 2006, 12, 3\u20138.", "ArticleIdList": ["PMC3291402", "16494709"]}, {"Citation": "Itzstein M. V.; Thomson R.. Anti-Influenza Drugs: The Development of Sialidase Inhibitors. In Antiviral Strategies, Handbook of Experimental 111 Pharmacology; Kr\u00e4usslich H. G., Bartenschlager R., Eds.; Springer-Verlag: Berlin, 2009; p 189.", "ArticleIdList": ["19048199"]}, {"Citation": "Colman P. M. Influenza Virus Neuraminidase: Structure, Antibodies, and Inhibitors. Protein Sci. 1994, 3, 1687\u20131696.", "ArticleIdList": ["PMC2142611", "7849585"]}, {"Citation": "Haskell T. H.; Peterson F. E.; Watson D.; Plessas N. R.; Culberts T. Neuraminidase Inhibition and Viral Chemotherapy. J. Med. Chem. 1970, 13, 697\u2013704.", "ArticleIdList": ["4318072"]}, {"Citation": "Gong J. Z.; Xu W. F.; Zhang J. Structure and Functions of Influenza Virus Neuraminidase. Curr. Med. Chem. 2007, 14, 113\u2013122.", "ArticleIdList": ["17266572"]}, {"Citation": "Gubareva L. V.; Kaiser L.; Hayden F. G. Influenza Virus Neuraminidase Inhibitors. Lancet 2000, 355, 827\u2013835.", "ArticleIdList": ["10711940"]}, {"Citation": "Burmeister W. P.; Ruigrok R. W. H.; Cusack S. The 2.2-a Resolution Crystal-Structure of Influenza-B Neuraminidase and Its Complex with Sialic-Acid. EMBO J. 1992, 11, 49\u201356.", "ArticleIdList": ["PMC556424", "1740114"]}, {"Citation": "von Itzstein M. The War against Influenza: Discovery and Development of Sialidase Inhibitors. Nat. Rev. Drug Discovery 2007, 6, 967\u2013974.", "ArticleIdList": ["18049471"]}, {"Citation": "De Clercq E. Antiviral Agents Active against Influenza a Viruses. Nat. Rev. Drug Discovery 2006, 5, 1015\u20131025.", "ArticleIdList": ["PMC7097821", "17139286"]}, {"Citation": "Coombes R. U. Stocks up on Antiviral Drug to Tackle Flu Outbreak. BMJ 2005, 330, 495\u2013495.", "ArticleIdList": ["PMC552801", "15746113"]}, {"Citation": "Jennings L. C.; Monto A. S.; Chan P. K. S.; Szucs T. D.; Nicholson K. G. Stockpiling Prepandemic Influenza Vaccines: A New Cornerstone of Pandemic Preparedness Plans. Lancet Infect. Dis. 2008, 8, 650\u2013658.", "ArticleIdList": ["18922487"]}, {"Citation": "Kamali A.; Holodniy M. Influenza Treatment and Prophylaxis with Neuraminidase Inhibitors: A Review. Infect. Drug Resist. 2013, 6, 187\u2013198.", "ArticleIdList": ["PMC3838482", "24277988"]}, {"Citation": "Dawood F. S.; Jain S.; Finelli L.; Shaw M. W.; Lindstrom S.; Garten R. J.; Gubareva L. V.; Xu X. Y.; Bridges C. B.; Uyeki T. M. Emergence of a Novel Swine-Origin Influenza a (H1N1) Virus in Humans Novel Swine-Origin Influenza a (H1N1) Virus Investigation Team. N. Engl. J. Med. 2009, 360, 2605\u20132615.", "ArticleIdList": ["19423869"]}, {"Citation": "Meijer A.; Lackenby A.; Hungnes O.; Lina B.; van der Werf S.; Schweiger B.; Opp M.; Paget J.; van de Kassteele J.; Hay A.; Zambon M.; Sc E. I. S. Oseltamivir-Resistant Influenza Virus a (H1N1), Europe, 2007\u201308 Season. Emerging Infect. Dis. 2009, 15, 552\u2013560.", "ArticleIdList": ["PMC2671453", "19331731"]}, {"Citation": "Moscona A. Global Transmission of Oseltamivir-Resistant Influenza. N. Engl. J. Med. 2009, 360, 953\u2013956.", "ArticleIdList": ["19258250"]}, {"Citation": "de Jong M. D.; Tran T. T.; Truong H. K.; Vo M. H.; Smith G. J.; Nguyen V. C.; Bach V. C.; Phan T. Q.; Do Q. H.; Guan Y.; Peiris J. S.; Tran T. H.; Farrar J. Oseltamivir Resistance During Treatment of Influenza a (H5N1) Infection. N. Engl. J. Med. 2005, 353, 2667\u20132672.", "ArticleIdList": ["16371632"]}, {"Citation": "Blundell T. L.; Sibanda B. L.; Montalvao R. W.; Brewerton S.; Chelliah V.; Worth C. L.; Harmer N. J.; Davies O.; Burke D. Structural Biology and Bioinformatics in Drug Design: Opportunities and Challenges for Target Identification and Lead Discovery. Philos. Trans. R. Soc., B 2006, 361, 413\u2013423.", "ArticleIdList": ["PMC1609333", "16524830"]}, {"Citation": "Rakers C.; Schwerdtfeger S. M.; Mortier J.; Duwe S.; Wolff T.; Wolber G.; Melzig M. F. Inhibitory Potency of Flavonoid Derivatives on Influenza Virus Neuraminidase. Bioorg. Med. Chem. Lett. 2014, 24, 4312\u20134317.", "ArticleIdList": ["25096296"]}, {"Citation": "Shan Y. Y.; Ma Y.; Wang M. Y.; Dong Y. L. Recent Advances in the Structure-Based Design of Neuraminidase Inhibitors as Anti-Influenza Agents. Curr. Med. Chem. 2012, 19, 5885\u20135894.", "ArticleIdList": ["22963668"]}, {"Citation": "Feng E. G.; Ye D. J.; Li J.; Zhang D. Y.; Wang J. F.; Zhao F.; Hilgenfeld R.; Zheng M. Y.; Jiang H. L.; Liu H. Recent Advances in Neuraminidase Inhibitor Development as Anti-Influenza Drugs. ChemMedChem. 2012, 7, 1527\u20131536.", "ArticleIdList": ["22807317"]}, {"Citation": "Dave K.; Gandhi M.; Panchal H.; Vaidya M. Revision of Qsar, Docking, and Molecular Modeling Studies of Anti-Influenza Virus a (H1N1) Drugs and Targets: Analysis of Hemagglutinins 3d Structure. Curr. Comput.-Aided Drug Des. 2011, 7, 255\u2013262.", "ArticleIdList": ["22050681"]}, {"Citation": "Wang J. Z.; Ma C. L.; Wang J.; Jo H.; Canturk B.; Fiorin G.; Pinto L. H.; Lamb R. A.; Klein M. L.; DeGrado W. F. Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31n, of the M2 Proton Channel from Influenza a Virus. J. Med. Chem. 2013, 56, 2804\u20132812.", "ArticleIdList": ["PMC4036227", "23437766"]}, {"Citation": "Gkeka P.; Eleftheratos S.; Kolocouris A.; Cournia Z. Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza a/M2tm Pore. J. Chem. Theory Comput. 2013, 9, 1272\u20131281.", "ArticleIdList": ["26588768"]}, {"Citation": "Harvey A. L. Natural Products in Drug Discovery. Drug Discovery Today 2008, 13, 894\u2013901.", "ArticleIdList": ["18691670"]}, {"Citation": "Newman D. J.; Cragg G. M. Natural Product Scaffolds as Leads-to Drugs. Future Med. Chem. 2009, 1, 1415\u20131427.", "ArticleIdList": ["21426057"]}, {"Citation": "Nagai T.; Moriguchi R.; Suzuki Y.; Tomimori T.; Yamada H. Mode of Action of the Anti-Influenza Virus Activity of Plant Flavonoid, 5,7,4\u2032-Trihydroxy-8-Methoxyflavone, from the Roots of Scutellaria Baicalensis. Antiviral Res. 1995, 26, 11\u201325.", "ArticleIdList": ["7741518"]}, {"Citation": "Grienke U.; Schmidtke M.; von Grafenstein S.; Kirchmair J.; Liedl K. R.; Rollinger J. M. Influenza Neuraminidase: A Druggable Target for Natural Products. Nat. Prod. Rep. 2012, 29, 11\u201336.", "ArticleIdList": ["22025274"]}, {"Citation": "Wahab H. A.; Asarudin M. R.; Ahmad S.; Mohamed N.; Rahim A. S. A.; Hamid S. A.; Osman H.; Shamsudin S.. Nature Based Drug Discovery (Nadi) & Its Application to Novel Neuraminidase Inhibitors Identification by Virtual Screening, Pharmacophore Modelling and Mapping of Malaysian Medicinal Plants; ICS-UNIDO: Trieste, Italy, 2009."}, {"Citation": "Petersen F. D.; Ren\u00e9 A.. Natural Compounds as Drugs; Springer: London, 2008."}, {"Citation": "Ogungbe I. V.; Setzer W. N. Comparative Molecular Docking of Antitrypanosomal Natural Products into Multiple Trypanosoma Brucei Drug Targets. Molecules 2009, 14, 1513\u20131536.", "ArticleIdList": ["PMC6254181", "19384282"]}, {"Citation": "Phosrithong N.; Ungwitayatorn J. Molecular Docking Study on Anticancer Activity of Plant-Derived Natural Products. Med. Chem. Res. 2010, 19, 817\u2013835."}, {"Citation": "Li C.; Xu L.; Wolan D. W.; Wilson I. A.; Olson A. J. Virtual Screening of Human 5-Aminoimidazole-4-Carboxamide Ribonucleotide Transformylase against the Nci Diversity Set by Use of Autodock to Identify Novel Nonfolate Inhibitors. J. Med. Chem. 2004, 47, 6681\u20136690.", "ArticleIdList": ["15615517"]}, {"Citation": "Rollinger J. M.; Steindl T. M.; Schuster D.; Kirchmair J.; Anrain K.; Ellmerer E. P.; Langer T.; Stuppner H.; Wutzler P.; Schmidtke M. Structure-Based Virtual Screening for the Discovery of Natural Inhibitors for Human Rhinovirus Coat Protein. J. Med. Chem. 2008, 51, 842\u2013851.", "ArticleIdList": ["18247552"]}, {"Citation": "Lipinski C. A. Lead- and Drug-Like Compounds: The Rule-of-Five Revolution. Drug Discovery Today: Technol. 2004, 1, 337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Liu T.; Lin Y.; Wen X.; Jorissen R. N.; Gilson M. K. Bindingdb: A Web-Accessible Database of Experimentally Determined Protein-Ligand Binding Affinities. Nucleic Acids Res. 2007, 35, D198\u2013201.", "ArticleIdList": ["PMC1751547", "17145705"]}, {"Citation": "Chen X.; Lin Y.; Liu M.; Gilson M. K. The Binding Database: Data Management and Interface Design. Bioinformatics 2002, 18, 130\u2013139.", "ArticleIdList": ["11836221"]}, {"Citation": "Greenwood J. R.; Calkins D.; Sullivan A. P.; Shelley J. C. Towards the Comprehensive, Rapid, and Accurate Prediction of the Favorable Tautomeric States of Drug-Like Molecules in Aqueous Solution. J. Comput.-Aided Mol. Des. 2010, 24, 591\u2013604.", "ArticleIdList": ["20354892"]}, {"Citation": "Shelley J. C.; Cholleti A.; Frye L. L.; Greenwood J. R.; Timlin M. R.; Uchimaya M. Epik: A Software Program for Pk(a) Prediction and Protonation State Generation for Drug-Like Molecules. J. Comput.-Aided Mol. Des. 2007, 21, 681\u2013691.", "ArticleIdList": ["17899391"]}, {"Citation": "Jorgensen W. L.; Maxwell D. S.; TiradoRives J. Development and Testing of the Opls All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J. Am. Chem. Soc. 1996, 118, 11225\u201311236."}, {"Citation": "Kaminski G. A.; Friesner R. A.; Tirado-Rives J.; Jorgensen W. L. Evaluation and Reparametrization of the Opls-Aa Force Field for Proteins Via Comparison with Accurate Quantum Chemical Calculations on Peptides. J. Phys. Chem. B 2001, 105, 6474\u20136487."}, {"Citation": "Sanner M. F. A Component-Based Software Environment for Visualizing Large Macromolecular Assemblies. Structure 2005, 13, 447\u2013462.", "ArticleIdList": ["15766546"]}, {"Citation": "Russell R. J.; Haire L. F.; Stevens D. J.; Collins P. J.; Lin Y. P.; Blackburn G. M.; Hay A. J.; Gamblin S. J.; Skehel J. J. The Structure of H5N1 Avian Influenza Neuraminidase Suggests New Opportunities for Drug Design. Nature 2006, 443, 45\u201349.", "ArticleIdList": ["16915235"]}, {"Citation": "Morris G. M.; Goodsell D. S.; Halliday R. S.; Huey R.; Hart W. E.; Belew R. K.; Olson A. J. Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function. J. Comput. Chem. 1998, 19, 1639\u20131662."}, {"Citation": "Weiner S. J.; Kollman P. A.; Case D. A.; Singh U. C.; Ghio C.; Alagona G.; Profeta S.; Weiner P. A New Force Field for Molecular Mechanical Simulation of Nucleic Acids and Proteins. J. Am. Chem. Soc. 1984, 106, 765\u2013784."}, {"Citation": "Gasteiger J.; Marsili M. Iterative Partial Equalization of Orbital Electronegativity--a Rapid Access to Atomic Charges. Tetrahedron 1980, 36, 3219\u20133228."}, {"Citation": "Morris G. M.; Goodsell D. S.; Huey R.; Hart W. E.; Halliday S.; Belew R.; Olson A. J.. Autodock: Automated Docking of Flexible Ligands to Receptors, version 3.0.5; Scripps Research Institute: San Diego, California, 2001."}, {"Citation": "Potier M.; Mameli L.; Belisle M.; Dallaire L.; Melancon S. B. Fluorometric Assay of Neuraminidase with a Sodium (4-Methylumbelliferyl-Alpha-D-N-Acetylneuraminate) Substrate. Anal. Biochem. 1979, 94, 287\u2013296.", "ArticleIdList": ["464297"]}, {"Citation": "Feng B. Y.; Shoichet B. K. A Detergent-Based Assay for the Detection of Promiscuous Inhibitors. Nat. Protoc. 2006, 1, 550\u2013553.", "ArticleIdList": ["PMC1544377", "17191086"]}, {"Citation": "Ryu H. W.; Curtis-Long M. J.; Jung S.; Jin Y. M.; Cho J. K.; Ryu Y. B.; Lee W. S.; Park K. H. Xanthones with Neuraminidase Inhibitory Activity from the Seedcases of Garcinia Mangostana. Bioorg. Med. Chem. 2010, 18, 6258\u20136264.", "ArticleIdList": ["20696581"]}, {"Citation": "Obolskiy D.; Pischel I.; Siriwatanametanon N.; Heinrich M.; Garcinia Mangostana L. A Phytochemical and Pharmacological Review. Phytother. Res. 2009, 23, 1047\u20131065.", "ArticleIdList": ["19172667"]}, {"Citation": "Pedraza-Chaverri J.; Cardenas-Rodriguez N.; Orozco-Ibarra M.; Perez-Rojas J. M. Medicinal Properties of Mangosteen (Garcinia Mangostana). Food Chem. Toxicol. 2008, 46, 3227\u20133239.", "ArticleIdList": ["18725264"]}, {"Citation": "Lian G. E. C.; Rahmani M. B. Available from http://km.upm.edu.my/kmportalweb/infox/assetDetailAction.action?execute=view&assetId=000001421&actionFlg=alllist."}, {"Citation": "Ryu Y. B.; Curtis-Long M. J.; Lee J. W.; Kim J. H.; Kim J. Y.; Kang K. Y.; Lee W. S.; Park K. H. Characteristic of Neuraminidase Inhibitory Xanthones from Cudrania Tricuspidata. Bioorg. Med. Chem. 2009, 17, 2744\u20132750.", "ArticleIdList": ["19285413"]}, {"Citation": "Feng B. Y.; Simeonov A.; Jadhav A.; Babaoglu K.; Inglese J.; Shoichet B. K.; Austin C. P. A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library. J. Med. Chem. 2007, 50, 2385\u20132390.", "ArticleIdList": ["17447748"]}, {"Citation": "Friesner R. A.; Banks J. L.; Murphy R. B.; Halgren T. A.; Klicic J. J.; Mainz D. T.; Repasky M. P.; Knoll E. H.; Shelley M.; Perry J. K.; Shaw D. E.; Francis P.; Shenkin P. S. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 2004, 47, 1739\u20131749.", "ArticleIdList": ["15027865"]}, {"Citation": "Halgren T. A.; Murphy R. B.; Friesner R. A.; Beard H. S.; Frye L. L.; Pollard W. T.; Banks J. L. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J. Med. Chem. 2004, 47, 1750\u20131759.", "ArticleIdList": ["15027866"]}, {"Citation": "Durrant J. D.; McCammon J. A. Binana: A Novel Algorithm for Ligand-Binding Characterization. J. Mol. Graphics Modell. 2011, 29, 888\u2013893.", "ArticleIdList": ["PMC3099006", "21310640"]}, {"Citation": "Stierand K.; Maass P. C.; Rarey M. Molecular Complexes at a Glance: Automated Generation of Two-Dimensional Complex Diagrams. Bioinformatics 2006, 22, 1710\u20131716.", "ArticleIdList": ["16632493"]}, {"Citation": "Stierand K.; Rarey M. Drawing the Pdb: Protein-Ligand Complexes in Two Dimensions. Acs. Med. Chem. Lett. 2010, 1, 540\u2013545.", "ArticleIdList": ["PMC4007829", "24900245"]}, {"Citation": "Humphrey W.; Dalke A.; Schulten K. Vmd: Visual Molecular Dynamics. J. Mol. Graphics 1996, 14, 33\u201338.", "ArticleIdList": ["8744570"]}, {"Citation": "Amaro R. E.; Swift R. V.; Votapka L.; Li W. W.; Walker R. C.; Bush R. M. Mechanism of 150-Cavity Formation in Influenza Neuraminidase. Nat. Commun. 2011, 2, 388.", "ArticleIdList": ["PMC3144582", "21750542"]}, {"Citation": "Wu Y.; Qin G. R.; Gao F.; Liu Y.; Vavricka C. J.; Qi J. X.; Jiang H. L.; Yu K. Q.; Gao G. F. Induced Opening of Influenza Virus Neuraminidase N2 150-Loop Suggests an Important Role in Inhibitor Binding. Sci. Rep. 2013, 3, 1551.", "ArticleIdList": ["PMC3609017", "23531861"]}, {"Citation": "Sharma A.; Tendulkar A. V.; Wangikar P. P. Drug Discovery against H1N1 Virus (Influenza a Virus) Via Computational Virtual Screening Approach. Med. Chem. Res. 2011, 20, 1445\u20131449."}, {"Citation": "Saha R. K.; Takahashi T.; Suzuki T. Glucosyl Hesperidin Prevents Influenza a Virus Replication in Vitro by Inhibition of Viral Sialidase. Biol. Pharm. Bull. 2009, 32, 1188\u20131192.", "ArticleIdList": ["19571383"]}, {"Citation": "Wang X. Y.; Jia W.; Zhao A. H.; Wang X. R. Anti-Influenza Agents from Plants and Traditional Chinese Medicine. Phytother. Res. 2006, 20, 335\u2013341.", "ArticleIdList": ["16619359"]}, {"Citation": "Warren G. L.; Andrews C. W.; Capelli A. M.; Clarke B.; LaLonde J.; Lambert M. H.; Lindvall M.; Nevins N.; Semus S. F.; Senger S.; Tedesco G.; Wall I. D.; Woolven J. M.; Peishoff C. E.; Head M. S. A Critical Assessment of Docking Programs and Scoring Functions. J. Med. Chem. 2006, 49, 5912\u20135931.", "ArticleIdList": ["17004707"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["25555059", "PMC4340357", "10.1021/ci500405g"]}}], "PubmedBookArticle": []}